Lv1
40 积分 2025-12-11 加入
Lifitegrast ophthalmic solution in the treatment of signs and symptoms of dry eye disease: design, development, and place in therapy
2个月前
已完结
Lifitegrast ophthalmic solution in the treatment of signs and symptoms of dry eye disease: design, development, and place in therapy
2个月前
已完结
Scleral contact lenses are not optically inferior to corneal lenses
2个月前
已完结
Scleral lenses for correction of irregular astigmatism: advances and limitations
2个月前
已完结
Altered functional connectivity between the default mode network in diabetic retinopathy patients
2个月前
已完结
Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies
2个月前
已完结
Real-world treatment patterns of OTX-101 ophthalmic solution, cyclosporine ophthalmic emulsion, and lifitegrast ophthalmic solution in patients with dry eye disease: a retrospective analysis
2个月前
已完结
Comparison of Dry Eye Treatment Outcomes in Patients with or without Autoimmune Disease
2个月前
已完结
Real-world treatment patterns of OTX-101 ophthalmic solution, cyclosporine ophthalmic emulsion, and lifitegrast ophthalmic solution in patients with dry eye disease: a retrospective analysis
2个月前
已完结
Lifitegrast in Treatment of Dry Eye Disease—A Practical, Narrative Expert Review
3个月前
已完结
皖公网安备34019202002308
